Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Conditions
T-cell Lymphoma · Cutaneous/Peripheral T-Cell Lymphoma · Peripheral T-cell Lymphoma · Peripheral T-Cell Lymphoma, Not Classified · Primary Cutaneous T-cell Lymphoma · Cutaneous T-Cell Lymphoma, Unspecified · Cutaneous T-cell Lymphoma · Follicular T-Cell Lymphoma · Angioimmunoblastic T-cell Lymphoma · Sézary's Disease · Mycosis Fungoides
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic Arizona, Scottsdale, Arizona, United States
Contact: Study coordinator (Breanna Keller)Contact: Principal Investigator (Aaron R Mangold, M.D.)City of Hope Medical Foundation, Duarte, California, United States
Contact: Study coordinator (Tracey Nguyen)Contact: Principal Investigator (Christiane Querfeld, M.D., Ph.D.)University of Southern California, Los Angeles, California, United States
Contact: Study coordinator (Christine Duran)Contact: Principal Investigator (Ann F Mohrbacher, M.D.)University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Contact: Principal Investigator (Brad Haverkos, M.D.)Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, United States
Contact: Study coordinator (Benjamin Joslin, MPH, CCRC)Contact: Principal Investigator (Jonathan Moreira, M.D.)University of Michigan, Ann Arbor, Michigan, United States
Contact: Study coordinator (Tina Jones)Contact: Principal Investigator (Ryan A Wilcox, MD, PhD)Barbara Ann Karmanos Cancer Institute Wayne State University, Detroit, Michigan, United States
Contact: Study coordinator (Erik Carr)Contact: Principal Investigator (Dipenkumar Modi, M.D.)Columbia University, New York, New York, United States
Contact: Study coordinator (Anxhela Kalia)Contact: Principal Investigator (Barbara Pro, M.D.)University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Charity L Ruhl, LPN)Contact: Principal Investigator (Oleg E Akilov, M.D., Ph.D.)The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Alda J Ashu, BSN, RN, OCN)Contact: Principal Investigator (Auris O Huen, MD, PharmD)
Study leads
Ali Moiin, MD
Study Director
SciTech Development, Inc.
Oleg E Akilov, MD, PhD
Principal Investigator
University of Pittsburgh Medical Center (UPMC)
Ann F Mohrbacher, MD
Principal Investigator
University of Southern California
Barbara Pro, MD
Principal Investigator
Columbia University
Dipenkumar Modi, MD
Principal Investigator
Barbara Ann Karmanos Cancer Institute
Auris O Huen, MD, PharmD
Principal Investigator
M.D. Anderson Cancer Center
Ryan A Wilcox, MD, PhD
Principal Investigator
University of Michigan
Brad Haverkos, M.D.
Principal Investigator
University of Colorado, Denver
Christiane Querfeld, M.D., Ph.D.
Principal Investigator
City of Hope Medical Foundation
Aaron R Mangold, M.D.
Principal Investigator
Mayo Clinic
Jonathan Moreira, M.D.
Study Director
Northwestern University, Robert H. Lurie Comprehensive Cancer Center